Tonghua Dongbao Pharmaceutical Co., Ltd. researches and develops, manufactures, and sells pharmaceutical products for the treatment of diabetes and cardiovascular-based diseases in China. The company operates through Pharmaceutical Industry and Building Materials Industry segments. Its lead product portfolio includes insulin analogues, such as insulin glargine, Insulin aspart, and insulin lispro; antidiabetic drugs; and oral hypoglycemic drugs, as well as Gan Shulin pens, blood glucose meters, and other medical devices. It offers building materials. The company has a strategic alliance with Adocia. Tonghua Dongbao Pharmaceutical Co., Ltd. was founded in 1985 and is based in Tonghua, China.

Tonghua Dongbao Pharmaceutical Co., Ltd.

阿里云企航提供域名产品、网站建设、商标软著、资质备案、案例库和移动端服务。

COM:THDB

阿里云企航

Last Close

8.77

12/11 07:00

Market Cap

15.02B

Beta: -

Volume Today

71.21M

Avg: -